Induction of anti-phospholipid autoantibodies by β2-glycoprotein I bound to apoptotic thymocytes

Journal of Autoimmunity

Volumn 11, Issue 5, 1998, Pages 413-424

  Levine, Jerrold S ^a   Subang, Rebecca ^b   Koh, Jason S ^a   Rauch, Joyce ^b  

^a BOSTON MEDICAL CENTER   (United States)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Anticardiolipin antibodies; Antiphospholipid antibodies; Apoptosis; Autoimmunity; 2 glycoprotein I

Indexed keywords

BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY; MONOCLONAL ANTIBODY; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY DETECTION; APOPTOSIS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; PROTEIN BINDING; SPECIES DIFFERENCE; THYMOCYTE;

EID: 0032191322     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1998.0235     Document Type: Conference Paper

References (47)

1. 1. McNeil H.P., Chesterman C.N., Krilis S.A. 1991. Immunology and clinical importance of antiphospholipid antibodies. Adv. Immunol. 49: 193-280
2. 2. Lockshin M.D. 1994. Antiphospholipid antibody syndromes. Rheum. Dis. Clin. North Am. 20: 45-49
3. 2-glycoprotein I (apolipoprotein H). Proc. Natl. Acad. Sci. USA 87: 4120-4124
4. 4. Matsuura E., Igarashi Y., Fujimoto M., Ichikawa K., Suzuki T., Sumida T., Yasuda T., Koike T. 1992. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J. Immunol. 148: 3885-3891
5. 2-glycoprotein I. J. Clin. Invest. 90: 1100-1104
6. 6. Gharavi A.E., Harris E.N., Asherson R.A., Hughes G.R.V. 1987. Anticardiolipin antibodies: Isotype distribution and phospholipid specificity. Ann. Rheum. Dis. 46: 1-6
7. 7. Triplett D.A., Brandt J.T., Musgrave K.A., Orr C.A. 1988. The relationship between lupus anticoagulants and antibodies to phospholipid. JAMA 259: 550-554
8. 8. Wurm H. 1984. β2-glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles. Int. J. Biochem. 16: 511-515
9. 9. Op den Kamp J.A.F. 1979. Lipid asymmetry in membranes. Ann. Rev. Biochem. 48: 47-71
10. 10. Bevers E.M., Comfurius P., Zwaal R.F.A. 1983. Changes in membrane phospholipid distribution during platelet activation. Biochim. Biophys. Acta 736: 57-66
11. 11. Fadok V.A., Voelker D.R., Campbell P.A., Cohen J.J., Bratton D.L., Henson P.M. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148: 2207-2216
12. 12. Price B.E., Rauch J., Shia M.A., Walsh M.T., Lieberthal W., Gilligan H.M., O'Laughlin T., Koh J.S., Levine J.S. 1996. Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a β2-glycoprotein I-dependent manner. J. Immunol. 157: 2201-2208
13. 13. Cohen J.J., Duke R.C. 1984. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol. 132: 38-42
14. 14. Brodeur B.R., Larose Y., Tsang P., Hamel J., Ashton F., Ryan A. 1985. Protection against infection with Neisseria meningitidis group B serotype 2b by passive immunization with serotype specific monoclonal antibody. Infect. Immunity 50: 510-516
15. 15. Rauch J., Janoff A.S. 1990. Phospholipid in the hexagonal phase is immunogenic: evidence for immunorecognition of nonbilayer lipid phases in vivo. Proc. Natl Acad. Sci. USA 87: 4112-4114
16. 16. Rauch J., Tannenbaum M., Janoff A.S. 1989. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids. Thromb. Haemost. 62: 892-986
17. 17. Gharavi A.E., Sammaritano L.R., Wen J., Elkon K.B. 1992. Induction of anti-phospholipid autoantibodies by immunization with β2 glycoprotein I (apolipoprotein H). J. Clin. Invest 90: 1105-1109
18. 18. Rauch J., Tannenbaum M., Tannenbaum H., Ramelson H., Cullis P.R., Tilcock C.P.S., Hope M.J., Janoff A.S. 1986. Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems. J. Biol. Chem. 261: 9672-9677
19. 19. Roubey R.A.S., Pratt C.W., Buyon J.P., Winfield J.B. 1992. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon β2-glycoprotein I. J. Clin. Invest. 90: 1100-1104
20. 20. Arvieux J., Pouzol P., Roussel B., Jacob M.C., Colomb M.G. 1992. Lupus-like anticoagulant properties of murine monoclonal antibodies to β2-glycoprotein I. Br. J. Haematol. 81: 568-573
21. 21. Arvieux J., Roussel B., Pouzol P., Colomb M.G. 1993. Platelet activating properties of murine monoclonal antibodies to β2-glycoprotein I. Thromb. Haemost. 70: 336-341
22. 22. Wagenknecht D.R., Mcintyre J.A. 1993. Changes in β2-glycoprotein I antigenicity induced by phospholipid binding. Thromb. Haemost. 69: 361-365
23. 23. Pierangeli S.S., Harris E.N. 1993. Induction of phospholipid-binding antibodies in mice and rabbits by immunization with human β2-glycoprotein I or anticardiolipin antibodies alone. Clin. Exp. Immunol. 93: 269-272
24. 24. Blank M., Faden D., Tincani A., Dopolovic J., Goldberg I., Gilburd B., Allegri F., Balestrieri G., Valesini G., Shoenfeld Y. 1994. Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J. Autoimmunity 7: 441-455
25. 25. Kouts S., Wang M.-X., Adelstein S., Krilis S.A. 1995. Immunization of a rabbit with β2-glycoprotein I induces charge-dependent crossreactive antibodies that bind anionic phospholipids and have similar reactivity as autoimmune anti-phospholipid antibodies. J. Immunol. 155: 958-966
26. 26. Silver R.M., Pierangeli S.S., Gharavi A.E., Harris E.N., Edwin S.S., Salafia C.A., Branch D.W. 1995. Induction of high levels of anticardiolpin antibodies in mice by immunization with β2-glycoprotein I does not cause fetal death. Am. J. Obstet. Gynecol. 173: 1410-1415
27. 27. Aron A.L., Cuellar M.L., Brey R.L., McKeown S., Espinoza L.R., Schoenfeld Y., Gharavi E. 1995. Early onset of auto immunity in MRL/ + + mice following immunization with β2-glycoprotein I. Clin. Exp. Immunol. 101: 78-81
28. 28. Matsuura E., Igrashi Y., Yasuda T., Triplett D., Koike T. 1994. Anticardiolipin antibodies recognize beta-2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J. Exp. Med. 179: 457-462
29. 29. Verrier Jones J., James H., Tan M.H., Mansour M. 1992. Antiphospholipid antibodies require β2-glycoprotein I (apolipoprotein H) as cofactor. J. Rheumatol. 19: 1397-1402
30. 30. Roubey R.A.S., Eisenberg R.A., Harper M.F., Winfield J.B. 1995. 'Anticardiolipin' autoantibodies recognize β2-glycoprotein I in the absence of phospholipid: importance of Ag density and bivalent binding. J. Immunol. 154: 954-960
31. 31. Tincani A., Spatola L., Prati E., Allegri F., Ferremi P., Cattaneo R., Meroni P., Balestrieri G. 1996. The anti-β2-glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native β2-glycoprotein I and preserved during species evolution. J. Immunol. 157: 5732-5738
32. 32. Hörkkö S., Miller E., Dudl E., Reaven P., Curtiss L.K., Zvaifler N.J., Terkeltaub R., Pierangeli S.S., Branch D.W., Palinski W., Witztum J.L. 1996. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids: recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J. Clin. Invest. 98: 815-825
33. 33. Mamula M.J., Fatenejed S., Craft J. 1994. B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J. Immunol. 152: 1453-1461
34. 34. James J.A., Gross T., Scofield R.H., Harley J.B. 1995. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B+-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J. Exp. Med. 181: 453-461
35. 35. Topper F., Gordon T., McCluskey J. 1995. Intra-and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A). Proc. Natl. Acad. Sci. USA 92: 875-879
36. 36. Scofield R.H., Henry W.E., Kurien B.T., James J.A., Harley J.B. 1996. Immunization with short peptides from the sequence of the systemic lupus erythematosus-associated 60-kDa Ro autoantigen results in anti-Ro ribonucleoprotein autoimmunity. J. Immunol. 156: 4059-4066
37. 37. Keech C.L., Gordon T.P., McCluskey J. 1996. The immune response to 52-kDa Ro and 60-kDa Ro is linked in experimental autoimmunity. J. Immunol. 157: 3694-3699
38. 38. Reynolds P., Gordon T.P., Purcell A.W., Jackson D.C., McCluskey J. 1996. Hierarchical self-tolerance to T cell determinants within the ubiquitous nuclear self-antigen La (SS-B) permits induction of systemic autoimmunity in normal mice. J. Exp. Med. 184: 1857-1870
39. 39. Mühlen C.A., Tan E.M. 1995. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin. Arthritis Rheum. 24: 323-358
40. 40. Koh J.S., Levine J.S. 1997. Apoptosis and autoimmunity. Curr. Opin. Nephrol. Hypertens. 6: 259-266
41. 41. Mohan C., Adams S., Stanik V., Datta D.K.. 1993. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177: 1367-1381
42. 42. Burlingame R.W., Boey M.L., Starkebaum G., Rubin R.L. 1994. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J. Clin. Invest. 94: 184-192
43. 43. Desai-Mehta A., Mao C., Rajagopalan S., Robinson T., Datta S.K. 1995. Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J. Clin. Invest. 95: 531-541
44. 44. Kaliyaperumal A., Mohan C., Wu W., Datta S.K. 1996. Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J. Exp. Med. 183: 2459-2469
45. 45. Casciola-Rosen L.A., Anhalt G., Rosen A. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface blebs on apoptotic keratinocytes. J. Exp. Med. 179: 1317-1330
46. 46. Casciola-Rosen L.A., Anhalt G., Rosen A. 1995. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J. Exp. Med. 182: 1625-1634
47. 47. Gilligan H.M., Bredy B., Brady H.M., Hébert M.-J., Slayter H.S., Xu, Y., Rauch J., Shia M.A., Koh J.S., Levine J.S. 1996. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J. Exp. Med. 184: 2231-2241